Valuation: The Hydration Pharmaceuticals Company Limited

Market Cap 1.14M 1.02M 939K 850K 1.59M 108M 1.61M 11.2M 4.47M 56.63M 4.26M 4.17M 179M P/E 2024
4.69x
P/E 2025 -0.45x
Enterprise Value 17.61K 15.78K 14.56K 13.17K 24.63K 1.68M 25.03K 174K 69.28K 878K 66.1K 64.7K 2.78M EV / Sales 2024
0.06x
EV / Sales 2025 0.13x
Free-Float
43.21%
Yield 2024 *
-
Yield 2025 -
1 week+50.00%
3 months-25.00%
Current year-40.00%
1 week 0
Extreme 0.002
0
1 month 0
Extreme 0.002
0
Current year 0
Extreme 0.002
0.01
1 year 0
Extreme 0.002
0.01
3 years 0
Extreme 0.002
0.04
5 years 0
Extreme 0.002
0.4
10 years 0
Extreme 0.002
0.4
Manager TitleAgeSince
Corporate Officer/Principal - 15/06/2026
Corporate Secretary - 08/02/2023
Director TitleAgeSince
Director/Board Member 53 08/02/2022
Chairman - 16/06/2026
Director/Board Member - 16/06/2026
Date Insider Type Main position Quantity % Market Cap. Importance
10/4/23 A Free

Chairman

500,000 0.2112%
10/4/23 A Buy

Director

333,333 0.1408%
10/4/23 A Free

Director

166,667 0.0704%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+50.00%-57.14%-89.29% 1.14M
+6.63%+5.13%+68.86%+145.20% 1,148B
+1.53%+2.84%+47.48%+89.01% 652B
+1.68%+1.96%+29.16%+109.31% 505B
+0.73%+2.45%+54.26%+68.96% 384B
+3.83%-0.62%+69.01%+42.32% 348B
+2.38%+2.65%+34.31%+57.95% 294B
+2.26%+0.55%+3.92%+28.92% 264B
+1.97%+3.01%+57.91%+76.14% 244B
+4.03%+5.36%+39.76%+116.14% 197B
Average +2.11%+2.18%+34.75%+64.47% 403.72B
Weighted average by Cap. +2.25%+2.89%+50.22%+95.97%

Financials

2024 2025
Net sales 3.2M 2.87M 2.65M 2.4M 4.48M 305M 4.55M 31.6M 12.61M 160M 12.03M 11.77M 506M 2.47M 2.21M 2.04M 1.85M 3.46M 235M 3.51M 24.37M 9.72M 123M 9.28M 9.08M 390M
Net income 2.67M 2.39M 2.2M 1.99M 3.73M 254M 3.79M 26.3M 10.49M 133M 10.01M 9.8M 421M -2.86M -2.56M -2.36M -2.14M -4M -272M -4.07M -28.2M -11.25M -143M -10.74M -10.51M -452M
Net Debt -3.22M -2.88M -2.66M -2.41M -4.5M -306M -4.57M -31.71M -12.65M -160M -12.07M -11.81M -508M -1.12M -1M -924K -836K -1.56M -107M -1.59M -11.03M -4.4M -55.75M -4.2M -4.11M -177M
Projected Income Statement - Annual - The Hydration Pharmaceuticals Company Limited
Logo The Hydration Pharmaceuticals Company Limited
The Hydration Pharmaceuticals Company Limited is an Australia-based hydration solutions company. The Company is focused on the sale and distribution of Hydralyte, which includes a product range of electrolyte-rich tablets, liquids, and powders. The Company markets and sells a range of liquid, tablet, and powder healthy hydration solutions products in the North American markets of Canada and the United States, under the Hydralyte brand. The Company operates as a wholesale supplier and online retailer of Hydralyte products in North America. The Company has a sales footprint in various markets, including the United States, Canada, Australia, New Zealand, Asia (excluding China, which includes Hong Kong but excludes Taiwan), Africa and the Middle East (excluding Turkey). Its subsidiaries include Hydration Pharmaceuticals Trust, Hydration Pharmaceuticals Canada, Hydralyte LLC, and others.
Employees
-
Date Price Change Volume
30/10/26 A$0.003000 0.00% 2,107,103
28/10/26 A$0.003000 0.00% 192,897
27/10/26 A$0.003000 +50.00% 2,386,222
23/10/26 A$0.002000 -33.33% 19,897,383
22/10/26 A$0.003000 0.00% 60,000